Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

PAZOPANIB-TEVA FC TABLETS 200 MG

Approval Number

SIN17000P

Drug Name

PAZOPANIB-TEVA FC TABLETS 200 MG

Product Name

PAZOPANIB-TEVA FC TABLETS 200 MG

Approval Date

May 8, 2024

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

L01XE11

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

PharOS MT Ltd

Active Ingredients

Ingredient Name

Pazopanib hydrochloride eqv Pazopanib

Strength

200 mg

Drug MonographPazopanib

Documents

Package Inserts

Pazopanib Teva PI.pdf

Approved: May 8, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy